Humacyte

+$0.02 (+0.43%) Today
+$0.19 (+4.03%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Humacyte and other ETFs, options, and stocks.

About HUMA

Humacyte, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets.

CEO
Laura E. Niklason
Employees
146
Headquarters
Durham, North Carolina
Founded
2004

HUMA Key Statistics

Market cap
485.15M
Price-Earnings ratio
—
Dividend yield
—
Average volume
498.28K
High today
$4.97
Low today
$4.44
Open price
$4.84
Volume
357.32K
52 Week high
$17.45
52 Week low
$4.27

HUMA Earnings

-$0.50
-$0.33
-$0.17
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.21 per share
Actual
-$0.19 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure